Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 815 results for "merck co"

Merck KGaA (ADR) (NYSE:MRK) Had Its TP Downgraded by 6.67 % at Goldman Sachs to $56.00

S&P Equity Research Reaffirms Hold Rating for Merck & Co., Inc...

Merck & Co., Inc. (NYSE:MRK)s stock had its hold rating restated by equities research analysts at S&P Equity Research in a research note issued on Friday, reports. They presently have a $56.00 price objective on the stock. S&P Equity ... Mideast Time, 2 hours ago

48 images for merck co

Irish Times, 2 days ago
Yahoo! India, 2 days ago
Business Insider, 2 days ago
Reuters, 2 days ago
Njbiz, 2 days ago, 2 days ago
4 Traders, 2 days ago
Investor's Business Daily, 2 days ago
Jutia Group, 6 days ago
Business Insider, 1 week ago

ImmunoGen/Merck Collaborate for Ovarian Cancer Study

ImmunoGen, Inc.'s IMGN shares gained 4.7% after the company announced that it has entered into clinical research collaboration agreement with Merck & Co. Inc. MRK to evaluate mirvetuximab soravtansine in combination with Merck's Keytruda ...
 Yahoo! Finance1 hour ago

FDA Approves Merck's Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection, in Combination with Other Antiemetic Agents, for the Prevention of Delayed Nausea and Vomiting in Adults Receiving Moderately Emetogenic Chemotherapy (MEC)

KENILWORTH, N.J.--( BUSINESS WIRE )--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for single-dose EMEND ...
 Business Wire1 day ago Merck's net profit dips by 87% in Q4 to $981 million  PharmaBiz1 day ago FDA approves new indication for Merck's Emend  Pharma Letter13 hours ago FDA Approves Merck & Co.'s Single-Dose EMEND (Fosaprepitant Dimeglumine) For Injection, In Combination With Other Antiemetic Agents, For The Prevention Of Delayed Nausea And Vomiting In Adults Receiving Moderately Emetogenic Chemotherapy (MEC)  BioSpace1 day ago

This Week In Pharma: Questions For Experts On Merck's ZEPATIER, Portola's Betrixaban

SLINGSHOT CONTRIBUTOR: Phil Loria Option 1: The potential for Merck's ( MRK ) recently approved Zepatier to impact the sales of GILD 's HARVONI and ABBV 's Viekira Pak Although Zepatier will be playing catch up to Viekira Pak and HARVONI, ...
 Seeking Alpha6 hours ago
Monthly Prescribing Reference

Merck receives FDA approval of hep C drug Zepatier

The FDA has approved Merck 's Zepatier (elbasvir and grazoprevir) for the treatment of adult patients with chronic hepatitis C virus (HCV) genotype (GT) 1 or GT4 infection, with or without ribavirin (RBV), following priority review by the FDA. ...
 Center Watch7 hours ago Merck Receives Approval of ZEPATIER (elbasvir/grazoprevir) in Canada for the Treatment of Chronic Hepatitis C for Patients with Genotype 1, 3, or 4 Infection Following Priority Review  Noodls2 days ago Generic Vytorin Gets Tentative FDA Approval  Monthly Prescribing Reference3 days ago
Motley Fool

2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried

Image source: Centers for Disease Control and Prevention. Houston, we may have a problem. Pharmaceutical juggernaut Merck ( NYSE:MRK ) reported its fourth-quarter earnings results before the opening bell on Wednesday, and while its Q4 profits ...
 Motley Fool1 day ago

Merck & Co., Inc. Falters After Q4 Report

Merck & Co., Inc. (NYSE: MRK ) shares are trading lower by $1.65 at $48.76 in Wednesday's session. Despite a Q4 EPS beat of $0.02 with slightly lower revenues, the Street is focusing on its lower FY 2016 outlook for EPS and revenues. After a ...
 Benzinga.com2 days ago Shares Of Merck Dip Lower Following Q4 Print  Benzinga.com2 days ago

3 - Merck Sharp & Dohme Research GmbH (0001665244) (Reporting)

Filing Date 2016-02-02 Accepted 2016-02-02 19:00:15 Documents 2 Period of Report 2016-02-02 Filing Date Changed 2016-02-02 Document Format Files Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 ...
 SEC3 days ago Complicated Skin and Skin Structure Infections (CSSSI) Global Clinical Trials Review, H2, 2015 - New Market Research Report  Digital Journal9 hours ago Epigenetics Market - Global Forecast to 2020 - Increasing Research Activities & High Prevalence of Cancer Driving Growth - Research and Markets  Minyanville9 hours ago Report Published: "B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2015"  Digital Journal9 hours ago
International Business Times

Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK) Join Race To Develop Zika Vaccine

To combat the menace of the Zika disease, Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK) have also joined the league of pharmaceuticals developing vaccines for the virus. The virus that is similar to dengue as it ...
 MyInforms1 day ago Pfizer, J&J, Merck evaluating technologies for Zika vaccine  Reuters2 days ago Is There A Vaccine For The Zika Virus? Pfizer, Johnson & Johnson, Merck Are Exploring Developing One  International Business Times2 days ago Big Names Like Johnson & Johnson, Merck & Co. and Pfizer Evaluate Technologies and Existing Vaccines for Ways to Fight Zika  BioSpace2 days ago

Merck's Blockbuster Drugs Are Losing Steam

Merck & Co mrk reported lower-than-expected quarterly revenue, hurt by a drop in sales of its diabetes and arthritis drugs, and a strong dollar. The company said sales of its diabetes drug, Januvia, fell 12% to $1.45 billion in the fourth ...
 Fortune2 days ago Merck gives cautious 2016 outlook as sales of top medicines lag  4 Traders2 days ago MERCK : revenue misses on lower drug sales, strong dollar  4 Traders2 days ago Merck revenue falls as dollar strengthens  Sharenet2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less